Search Results

Optimizing Adjuvant Taxanes in Early Breast Cancer.

• Authors : Martin M; Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense, Madrid, Spain .; López-Tarruella S

Subjects: Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy ; Paclitaxel/Paclitaxel/Paclitaxel/*administration & dosage

• Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2015 Jul 20; Vol. 33 (21), pp. 2334-6. Date Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model:

Record details

Taxanes alone or in combination with anthracyclines as first-line therapy of patients with metastatic breast cancer.

• Authors : Piccart-Gebhart MJ; Institut Jules Bordet, 121 boulevard de Waterloo, 1000 Brussels, Belgium. ; Burzykowski T

Subjects: Anthracyclines/Anthracyclines/Anthracyclines/*therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/Antineoplastic Combined Chemotherapy Protocols/*therapeutic use ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*drug therapy

• Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2008 Apr 20; Vol. 26 (12), pp. 1980-6.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

The activity of taxanes in the treatment of sex cord-stromal ovarian tumors.

• Authors : Brown J; Department of Gynecologic Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. ; Shvartsman HS

Subjects: Platinum Compounds*/Platinum Compounds*/Platinum Compounds*/therapeutic use; Ovarian Neoplasms/Ovarian Neoplasms/Ovarian Neoplasms/*drug therapy ; Sex Cord-Gonadal Stromal Tumors/Sex Cord-Gonadal Stromal Tumors/Sex Cord-Gonadal Stromal Tumors/*drug therapy

• Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2004 Sep 01; Vol. 22 (17), pp. 3517-23.Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print

Record details

Prognostic Value of the Modeled Prostate-Specific Antigen KELIM Confirmation in Metastatic Castration-Resistant Prostate Cancer Treated With Taxanes in FIRSTANA.

• Authors : Carrot, Aurore; Oudard, Stéphane; Colomban, Olivier

Subjects: CASTRATION-resistant prostate cancer; CLINICAL trials; ANDROGEN deprivation therapy

• Source: JCO Clinical Cancer Informatics; 12/1/2024, Vol. 8, p1-9, 9p

Record details

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study.

• Authors : Copeland, Larry J.; Brady, Mark F.; Burger, Robert A.

• Source: Journal of Clinical Oncology; 12/10/2022, Vol. 40 Issue 35, p4119-4128, 10p

Record details

Pyrotinib or Lapatinib Combined With Capecitabine in HER2–Positive Metastatic Breast Cancer With Prior Taxanes, Anthracyclines, and/or Trastuzumab: A Randomized, Phase II Study.

• Authors : Ma, Fei; Ouyang, Quchang; Li, Wei

• Source: Journal of Clinical Oncology; 10/10/2019, Vol. 37 Issue 29, p2610-2619, 15p

Record details

Hypersensitivity reaction to taxanes following COVID-19 vaccination.

• Authors : Osantowski, Bennett; Ondeck, Mariah; Lopetegui-Lia, Nerea

• Source: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3092-3092, 1p

Record details

Phase II Trial of Sorafenib in Patients With Metastatic Breast Cancer Previously Exposed to Anthracyclines or Taxanes: North Central Cancer Treatment Group and Mayo Clinic Trial N0336.

• Source: Journal of Clinical Oncology; 1/1/2009, Vol. 27 Issue 1, p11-15, 5p

Record details

Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer.

• Source: Journal of Clinical Oncology; 4/20/2008, Vol. 26 Issue 12, p1980-1986, 7p

Record details

Phase II Trial of Ixabepilone, an Epothilone B Analog, in Patients With Metastatic Breast Cancer Previously Untreated With Taxanes.

• Source: Journal of Clinical Oncology; 8/10/2007, Vol. 25 Issue 23, p3421-3427, 7p

Record details